Neurofeedback Systems Market Size, Share & Trends Analysis Report By Type (Frequency Neurofeedback System, Low Energy Neurofeedback System, Slow Cortical Potential Neurofeedback System, Hemoencephalographic Neurofeedback System, Low-Resolution Electromagnetic Tomography, Functional Magnetic Resonance Imaging), By Application (Attention Deficit Hyperactivity Disorder (ADHD), Pain Management, Insomnia, Anxiety Disorder, Other Diseases) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Neurofeedback Systems Market Size & Growth Analysis

The global neurofeedback systems market size was valued at USD 1.33 billion in 2025 and is projected to grow from USD 1.43 billion in 2026 to USD 2.56 billion by 2034, registering a CAGR of 7.53% during the forecast period from 2026 to 2034. North America dominated the neurofeedback systems market with a market share of 38.5% in 2025.

Market Segmentation

Type Insights

The market includes Frequency Neurofeedback, Low Energy Neurofeedback, Slow Cortical Potential Neurofeedback, Hemoencephalographic Neurofeedback, Low-Resolution Electromagnetic Tomography, and Functional Magnetic Resonance Imaging Systems. The Frequency Neurofeedback system section is projected to advance significantly and hold the largest market share over the forecast period. Its popularity among neurologists and the convenience and simplicity of operation are the main characteristics promoting its good growth. Surface neurofeedback is commonly referred to because it uses 2 to 4 surface electrodes. It alters the amplitude and frequency of certain brain waves to treat neurological conditions like ADHD, sleeplessness, and anxiety.

Request Customizationto receive a tailored report.

Application Insights

The market includes Attention Deficit Hyperactivity Disorder (ADHD), Pain Management, Insomnia, Anxiety Disorder, and Other Diseases. The ADHD section is projected to advance at a CAGR of 8.2% and hold the largest market share over the forecast period. The most prevalent neurodevelopmental illness in children is attention deficit hyperactivity disorder (ADHD). It frequently persists into maturity and is typically first diagnosed in infancy. Patients with ADHD, especially children, may struggle to regulate impulsive behavior, pay attention, or stop being overly active. The expanding emphasis on neurofeedback therapy, equipment research and development, and the increasing prevalence of ADHD globally are two significant drivers driving the segment's rise. Additionally, the increased emphasis on research and development is creating robust neurofeedback systems, boosting the industry.

The Insomnia section will hold the second-largest share. Insomnia is a common sleep problem that can make it difficult to fall asleep, difficult to stay asleep or cause early awakening and difficulties falling back asleep. After waking up, those who have insomnia can still feel exhausted. The main drivers of market expansion are the prevalence of insomniacs, the execution of strategic efforts by market participants, and the increased emphasis on the study and creation of neurofeedback systems for sleep disorders. The market is expanding due to the increased usage of neurofeedback devices for treating insomnia and the increased focus on research and development of neurofeedback systems.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America Market Share

North America will command the maximum market share, expanding at a CAGR of 7.9% over the forecast period. North America essentially drives the growth of this market due to its sophisticated healthcare infrastructure and numerous medical device businesses that are well-connected with hospitals. Since many companies choose to conduct their clinical advancement efforts in developed markets, primarily the United States, North America is also the region that has contributed most to the market's expansion. The increased incidence of the target diseases in this area is a significant factor fueling the market's growth. Up to 20% of Americans have insomnia each year, according to the American Academy of Sleep Medicine 2020.

Behavioral insomnia affects 30% of children and is particularly common in children with poor sleep habits. Additionally, 40 million Americans aged 18 and older may experience an anxiety illness each year in 2020, according to the Anxiety and Depression Disorders Association of America (ADAA). Thus, this region's high prevalence of insomnia and anxiety disorders promotes the demand for neurofeedback systems, fueling the market's expansion. The introduction of new products by numerous firms also contributes to the market's growth. For instance, in 2019, Narbis made its brand-exclusive Narbis smart glasses available. These glasses use neurofeedback principles and a NASA-developed algorithm to boost concentration and decrease drowsiness while reading, using a computer, studying, or doing online assignments. The market for neurofeedback systems is also fueled by numerous foundations, which serve as support networks for numerous healthcare professionals involved in treating brain dysfunctions.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Market Growth

Europe will likely generate USD 529 million, growing at a CAGR of 7.3% over the forecast period. One of the biggest neurofeedback markets in Europe is Germany, and it is anticipated to develop significantly during the projection period. The market in Germany is expanding due to factors such as the rising incidence of chronic diseases, the aging population, the increasing demand for efficient products, and beneficial initiatives by the major industry participants. According to the Alzheimer Europe 2019 study, there were around 1,585,166 dementia sufferers in Germany in 2018; by 2050, this number is expected to increase to 2,748,178. Similarly, the proportion of people with dementia in the general population will increase from 1.91% in 2018 to 3.43% in 2050. In the upcoming years, it's anticipated that there will be an increase in dementia cases, which will benefit the market. Dementia and other neurological illnesses are treated with the neurofeedback system. So, this is anticipated to promote market expansion.

List of Key and Emerging Players in Neurofeedback Systems Market